U.S. PHARMACOPEIA

Search USP29  
Estrone
Click to View Image
C18H22O2 270.37

Estra-1,3,5(10)-trien-17-one, 3-hydroxy-.
3-Hydroxyestra-1,3,5(10)-trien-17-one [53-16-7].
» Estrone contains not less than 97.0 percent and not more than 103.0 percent of C18H22O2, calculated on the dried basis.
Packaging and storage— Preserve in tight, light-resistant containers. Store at 25, excursions permitted between 15 and 30.
Clarity of solution— Add 100 mg to 100 mL of 1 N sodium hydroxide in a 125-mL conical flask, heat on a steam bath until solution is complete, then cool, and transfer to a 100-mL color-comparison tube: the solution is clear.
Identification—
B: Ultraviolet Absorption 197U
Solution: 50 µg per mL.
Medium: alcohol, heated on a steam bath and cooled to room temperature.
Specific rotation 781S: between +158 and +165.
Test solution: 10 mg, previously dried, per mL, in dioxane.
Loss on drying 731 Dry it at 105 for 3 hours: it loses not more than 0.5% of its weight.
Residue on ignition 281: not more than 0.5%.
Limit of equilenin and equilin— Dissolve 10 mg in sufficient alcohol to make 50 mL. Transfer 5 mL of the solution to a small beaker. Add 5 mL of a buffer solution prepared by dissolving 2 mL of glacial acetic acid and 13.3 g of anhydrous sodium acetate in water to make 100 mL, warm to about 50, and add 1 mL of a freshly prepared 1 in 200 solution of 2,6-dibromoquinone-chlorimide in alcohol. Mix, and allow to stand for 30 minutes. Transfer the solution to a small separator, add 10 mL of chloroform and 20 mL of 1 N sodium hydroxide, and shake vigorously for 2 minutes. Separate the chloroform layer, and filter rapidly through a dry filter paper into a dry test tube, discarding the first 2 mL of the filtrate. Viewed transversely against a white background, the chloroform filtrate shows no more red color than that produced by similarly treating 5 mL of an alcohol solution containing 20 µg of equilenin.
Ordinary impurities 466
Test solution: acetone.
Standard solution: acetone.
Eluant: a mixture of chloroform and acetone (9:1), in a nonequilibrated chamber.
Visualization: 5.
Residual solvents 467: meets the requirements.
(Official January 1, 2007)
Assay—
Mobile phase— Prepare a filtered and degassed mixture of acetonitrile and 0.05 M monobasic potassium phosphate (1:1). Make adjustments if necessary (see System Suitability under Chromatography 621).
Standard preparation— Transfer about 20 mg of USP Estrone RS, accurately weighed, to a 100-mL volumetric flask, add methanol to volume, and mix. If necessary, sonicate to aid solution. Transfer 5 mL of this solution to a 25-mL volumetric flask, dilute with Mobile phase to volume, and mix to obtain a Standard preparation having a known concentration of about 40 µg of USP Estrone RS per mL.
Assay preparation— Transfer about 20 mg of Estrone, accurately weighed, to a 100-mL volumetric flask, add methanol to volume, and mix. If necessary, sonicate to aid solution. Transfer 5.0 mL of this solution to a 25-mL volumetric flask, dilute with Mobile phase to volume, and mix.
Chromatographic system (see Chromatography 621)— The liquid chromatograph is equipped with a 280-nm detector and a 4-mm × 15-cm column that contains 5-µm packing L1. The flow rate is about 1 mL per minute. Chromatograph the Standard preparation, and record the peak responses as directed for Procedure: the column efficiency determined from the analyte peak is not less than 1500 theoretical plates, the tailing factor for the analyte peak is not more than 2.0, and the relative standard deviation for replicate injections is not more than 2.0%.
Procedure— Separately inject equal volumes (about 50 µL) of the Standard preparation and the Assay preparation into the chromatograph, record the chromatograms, and measure the responses for the major peaks. Calculate the quantity, in mg, of C18H22O2 in the portion of Estrone taken by the formula:
0.5C(rU / rS),
in which C is the concentration, in µg per mL, of USP Estrone RS in the Standard preparation; and rU and rS are the peak responses obtained from the Assay preparation and the Standard preparation, respectively.
Auxiliary Information— Staff Liaison : Daniel K. Bempong, Ph.D., Scientist
Expert Committee : (MDPS05) Monograph Development-Pulmonary and Steroids
USP29–NF24 Page 853
Pharmacopeial Forum : Volume No. 29(5) Page 1479
Phone Number : 1-301-816-8143